Endotelix

Plan-les-ouates, Switzerland

Endotelix is providing solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.

$100K raised

Mar 2023

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Endotelix raised?

Endotelix has raised $100K in total funding. The most recent round was Debt Financing. The last funding was announced in March 2023.

Who are Endotelix's investors?

Endotelix's investors include Venture Kick, FONGIT Innovation Fund.

Where is Endotelix headquartered?

Endotelix is headquartered in Plan-les-ouates, Switzerland.

What does Endotelix do?

Endotelix is providing solutions for Antiphospholipid Syndrome, including diagnostic tests and therapies.

What stage is Endotelix at?

Endotelix is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 16, 2023.

MLA

"Endotelix — Funding & Investors." VCBacked, March 16, 2023, https://www.vcbacked.co/company/endotelix. Accessed July 2, 2026.

APA

VCBacked. (2023). Endotelix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/endotelix

Wikipedia (cite web)

{{cite web |title=Endotelix — Funding & Investors |url=https://www.vcbacked.co/company/endotelix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 16, 2023.